Rehabilitation therapy

Rehabilitation therapy has been studied in 9 papers since 2018: 5 trials and 3 observational studies in people; 3 in the past year. The newest paper, Mar 13, 2026: “The role of early intervention with upper limb rehabilitation robots in upper limb functional reconstruction and improving sarcopenia-related indicators in stroke patients”.

Intervention

9 papers study it9 findingsUpdated

See all 9 papers on rehabilitation therapy

At a glance

Independent labs found the same change in people. 5 independent labs in 3 countries.

“mean (SD) cumulative costs per patient were $26 421 ($38 955) in the intervention group (excluding intervention costs) and $27 650 ($30 712) in the control group (difference, -$1229; 95% CI, -$8159 to $6394; P = .80)”
Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical TrialJAMA cardiology2021doi:10.1001/jamacardio.2021.4836

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 5 independent labs in 3 countries
  • Funders: National Institute on Aging and 8 more
  • 4 of 9 findings with company ties
  • Human trial5
  • Humans3

Studies in people

2 studies gave rehabilitation therapy to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on cumulative medical costsdifference, -$1229; 95% CI, -$8159 to $6394

up: Improves quality of lifemean utility difference, 0.074

Randomized trial6 months349 peopleBoth60 years or olderOlder adults; acute decompensated heart failureJAMA cardiology, Nov 25, 2021

up: Improves physical function+1.9 (95% CI: 1.1-2.6)

up: Improves global rank of death, all-cause rehospitalization, and SPPBprobability index 0.59 (95% CI: 0.50-0.68)

Randomized trial3 months185 peopleBotholderOlder adults; HFpEFJACC. Heart failure, Jul 7, 2021

What did studies of rehabilitation therapy find?

8

Studies of rehabilitation therapy measured 8 outcomes, among them quality of life, inflammation and apelin.

Quality of life

upin humans2

2 studies
  1. Rehabilitation therapy improves quality of life in humans (acute decompensated heart failure) (mean utility difference, 0.074).

    Human trialacute decompensated heart failure6 monthsn = 349

  2. Rehabilitation therapy is linked with better quality of life in humans (before and after 4-6 weeks of rehabilitation) (p < 0.001).

    Humansbefore and after 4-6 weeks of rehabilitation4-6 weeksn = 23

Inflammation

downin humans1

1 study
  1. Rehabilitation therapy is linked with lower inflammation in humans (cytokine profiles after rehabilitation).

    Humanscytokine profiles after rehabilitation4-6 weeksn = 23

More on Inflammation

Apelin

upin humans1

1 study
  1. Rehabilitation therapy is linked with higher apelin in humans (before and after 4-6 weeks of rehabilitation) (46.81 to 59.23 ng/mL).

    Humansbefore and after 4-6 weeks of rehabilitation4-6 weeksn = 23

More on Apelin

Functional recovery

upin humans1

1 study
  1. Rehabilitation therapy is linked with better functional recovery in humans (subacute stroke) (B=1.289, β=0.290, 95% CIs: 0.718-1.859, P<0.001).

    Humanssubacute stroke

Cumulative medical costs

no changein humans1

1 study
  1. Rehabilitation therapy showed no clear effect on cumulative medical costs in humans (acute decompensated heart failure) (difference, -$1229; 95% CI, -$8159 to $6394).

    Human trialacute decompensated heart failure6 monthsn = 349

Activities of daily living

upin humans1

1 study
  1. Rehabilitation therapy is linked with better activities of daily living in humans during rehabilitation therapy.

    Humansduring rehabilitation therapy3 weeksfemales

Global rank of death, all-cause rehospitalization, and SPPB

upin humans1

1 study
  1. Rehabilitation therapy improves global rank of death, all-cause rehospitalization, and SPPB in humans (HFpEF) (probability index 0.59 (95% CI: 0.50-0.68)).

    Human trialHFpEF6 monthsn = 185

Physical function

upin humans1

1 study
  1. Rehabilitation therapy improves physical function in humans (HFpEF) (+1.9 (95% CI: 1.1-2.6)).

    Human trialHFpEF3 monthsn = 185

Funding

3 grants since 2018

National Institute on Aging$1.5MUK Research and Innovation£50.3K

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 03 papers in 12 months